These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 34347332)
21. Results from a mobile drug checking pilot program using three technologies in Chicago, IL, USA. Karch L; Tobias S; Schmidt C; Doe-Simkins M; Carter N; Salisbury-Afshar E; Carlberg-Racich S Drug Alcohol Depend; 2021 Nov; 228():108976. PubMed ID: 34536717 [TBL] [Abstract][Full Text] [Related]
22. Responding to changes in the unregulated drug supply: the need for a dynamic approach to drug checking technologies. Bhuiyan I; Tobias S; Ti L Am J Drug Alcohol Abuse; 2023 Nov; 49(6):685-690. PubMed ID: 37506334 [TBL] [Abstract][Full Text] [Related]
23. Current attitudes toward drug checking services and a comparison of expected with actual drugs present in street drug samples collected from opioid users. Swartz JA; Lieberman M; Jimenez AD; Mackesy-Amiti ME; Whitehead HD; Hayes KL; Taylor L; Prete E Harm Reduct J; 2023 Jul; 20(1):87. PubMed ID: 37420196 [TBL] [Abstract][Full Text] [Related]
24. Xylazine detected in unregulated opioids and drug administration equipment in Toronto, Canada: clinical and social implications. Bowles JM; McDonald K; Maghsoudi N; Thompson H; Stefan C; Beriault DR; Delaney S; Wong E; Werb D Harm Reduct J; 2021 Oct; 18(1):104. PubMed ID: 34645480 [TBL] [Abstract][Full Text] [Related]
25. A survey of North American drug checking services operating in 2022. Park JN; Tardif J; Thompson E; Rosen JG; Lira JAS; Green TC Int J Drug Policy; 2023 Nov; 121():104206. PubMed ID: 37797571 [TBL] [Abstract][Full Text] [Related]
26. Evaluating Technologies to Identify Fentanyl and Adulterants in Street Drug Paraphernalia: Qualitative Perspectives of Service Providers and Their Clientele. Santelices C; Matsumoto A; Boulad M; Stopka TJ Subst Use Misuse; 2023; 58(12):1528-1535. PubMed ID: 37424449 [No Abstract] [Full Text] [Related]
27. How do we understand the value of drug checking as a component of harm reduction services? A qualitative exploration of client and provider perspectives. Moran L; Ondocsin J; Outram S; Ciccarone D; Werb D; Holm N; Arnold EA Harm Reduct J; 2024 May; 21(1):92. PubMed ID: 38734643 [TBL] [Abstract][Full Text] [Related]
28. Recommendations from people who use drugs in Philadelphia, PA about structuring point-of-care drug checking. Reed MK; Borne E; Esteves Camacho T; Kelly M; Rising KL Harm Reduct J; 2024 Jan; 21(1):26. PubMed ID: 38287409 [TBL] [Abstract][Full Text] [Related]
29. Detecting fentanyl using point-of-care drug checking technologies: A validation study. Ti L; Tobias S; Lysyshyn M; Laing R; Nosova E; Choi J; Arredondo J; McCrae K; Tupper K; Wood E Drug Alcohol Depend; 2020 Jul; 212():108006. PubMed ID: 32438280 [TBL] [Abstract][Full Text] [Related]
30. Drug checking services at music festivals and events in a Canadian setting. McCrae K; Tobias S; Tupper K; Arredondo J; Henry B; Mema S; Wood E; Ti L Drug Alcohol Depend; 2019 Dec; 205():107589. PubMed ID: 31605958 [TBL] [Abstract][Full Text] [Related]
31. An assessment of the limits of detection, sensitivity and specificity of three devices for public health-based drug checking of fentanyl in street-acquired samples. Green TC; Park JN; Gilbert M; McKenzie M; Struth E; Lucas R; Clarke W; Sherman SG Int J Drug Policy; 2020 Mar; 77():102661. PubMed ID: 31951925 [TBL] [Abstract][Full Text] [Related]
32. The potential impacts of community drug checking within the overdose crisis: qualitative study exploring the perspective of prospective service users. Wallace B; van Roode T; Pagan F; Hore D; Pauly B BMC Public Health; 2021 Jun; 21(1):1156. PubMed ID: 34134698 [TBL] [Abstract][Full Text] [Related]
33. Drug checking identifies counterfeit alprazolam tablets. Tobias S; Shapiro AM; Grant CJ; Patel P; Lysyshyn M; Ti L Drug Alcohol Depend; 2021 Jan; 218():108300. PubMed ID: 33127185 [TBL] [Abstract][Full Text] [Related]
34. Drug checking at an electronic dance music festival during the public health overdose emergency in British Columbia. Mema SC; Sage C; Xu Y; Tupper KW; Ziemianowicz D; McCrae K; Leigh M; Munn MB; Taylor D; Corneil T Can J Public Health; 2018 Dec; 109(5-6):740-744. PubMed ID: 30251119 [TBL] [Abstract][Full Text] [Related]
36. Toward automated infrared spectral analysis in community drug checking. Gozdzialski L; Hutchison A; Wallace B; Gill C; Hore D Drug Test Anal; 2024 Jan; 16(1):83-92. PubMed ID: 37248686 [TBL] [Abstract][Full Text] [Related]
37. Emerging synthetic cannabinoids detected by a drug checking service in Toronto, Canada. Scarfone KM; Maghsoudi N; McDonald K; Thompson H; Stefan C; Beriault DR; Werb D; Bowles JM Clin Toxicol (Phila); 2022 Aug; 60(8):979-984. PubMed ID: 35546568 [TBL] [Abstract][Full Text] [Related]
38. Implementation opportunities and challenges to piloting a community-based drug-checking intervention for sexual and gender minority men in Vancouver, Canada: a qualitative study. Coulaud PJ; Chayama KL; Schwartz C; Purdie A; Lysyshyn M; Ti L; Knight R Harm Reduct J; 2024 Apr; 21(1):87. PubMed ID: 38678256 [TBL] [Abstract][Full Text] [Related]
39. "I couldn't live with killing one of my friends or anybody": A rapid ethnographic study of drug sellers' use of drug checking. Betsos A; Valleriani J; Boyd J; Bardwell G; Kerr T; McNeil R Int J Drug Policy; 2021 Jan; 87():102845. PubMed ID: 33246303 [TBL] [Abstract][Full Text] [Related]
40. High willingness to use rapid fentanyl test strips among young adults who use drugs. Krieger MS; Yedinak JL; Buxton JA; Lysyshyn M; Bernstein E; Rich JD; Green TC; Hadland SE; Marshall BDL Harm Reduct J; 2018 Feb; 15(1):7. PubMed ID: 29422052 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]